Related Experiment Video
Updated: Aug 6, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
Published on: June 9, 2023
Anticancer potential of Viola cornuta-derived green-synthesized CuO nanoparticles via ROS-induced apoptosis in breast
Maryam Fekri Soufiabadi1, Mahsa Ziasistani1, Hannaneh Bazgir1
1Pathology and Stem Cell Research Center, Kerman University of Medical Sciences, Kerman, Iran.
Abstract:
Breast cancer is associated with significant mortality amongst women universally. Common treatments face various difficulties, including the development of drug resistance. This fact necessitates the exploration of new therapeutic protocols. Our study evaluated the apoptotic effects of green-synthesized copper oxide nanoparticles (CuO-NPs) on breast cancer cells (MCF7) compared to normal epithelial cells (MCF10) through a series of in vitro assays. Copper oxide nanoparticles were obtained from Viola corneta leaves. The crystalline structure and spherical morphology of the nanoparticles were represented by X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), and scanning electron microscopy (SEM). Cells were treated with multiple concentrations of CuO-NPs. Cell viability assay revealed dose-dependent IC50 values of 35.4 µg/mL and 85 µg/mL for MCF7 and MCF10A, respectively. CuO-NPs remarkably promoted ROS production and induced apoptosis, as evidenced by Annexin V/PI staining. Flow cytometric analysis exhibited a marked rise in the SubG1 phase of the cell cycle in the MCF7 population. Ultimately, real-time PCR analysis also exhibited a higher expression of pro-apoptotic than anti-apoptotic genes in treated cells. These findings emphasize the ability of CuO-NPs to induce apoptosis in breast cancer cell lines and highlight their effectiveness in selectively targeting the cancer cells rather than the normal cells.
Insights
Green-synthesized copper oxide nanoparticles (CuO-NPs) show promise in targeting breast cancer cells. These nanoparticles effectively induce apoptosis in cancer cells while sparing normal cells, offering a potential new therapeutic avenue.
Area of Science:
- Nanotechnology
- Biomedical Engineering
- Oncology
Background:
- Breast cancer poses a significant global health challenge, with current treatments often hampered by drug resistance.
- Novel therapeutic strategies are crucial to overcome treatment limitations and improve patient outcomes.
Purpose of the Study:
- To evaluate the in vitro apoptotic effects of green-synthesized copper oxide nanoparticles (CuO-NPs) on human breast cancer cells (MCF7).
- To compare the efficacy and selectivity of CuO-NPs against normal epithelial cells (MCF10A).
Main Methods:
- Green synthesis of CuO-NPs using Viola corneta leaf extract.
- Characterization of CuO-NPs using XRD, FTIR, and SEM.
- In vitro assays including cell viability, ROS production, Annexin V/PI staining, cell cycle analysis, and gene expression profiling.
Main Results:
- CuO-NPs demonstrated selective toxicity, with lower IC50 values for MCF7 cells (35.4 µg/mL) compared to MCF10A cells (85 µg/mL).
- Treatment with CuO-NPs significantly increased reactive oxygen species (ROS) production and induced apoptosis in MCF7 cells.
- Flow cytometry revealed an increase in the SubG1 phase, indicating cell cycle arrest, and real-time PCR showed altered expression of apoptosis-related genes.
Conclusions:
- Green-synthesized CuO-NPs effectively induce apoptosis in breast cancer cells.
- CuO-NPs exhibit selective cytotoxicity, targeting cancer cells while minimizing damage to normal cells.
- These findings suggest CuO-NPs as a potential therapeutic agent for breast cancer treatment.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...